A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
- 1 June 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 153 (6) , 1037-1047
- https://doi.org/10.1016/j.ahj.2007.02.037
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2European Respiratory Journal, 2004
- Clinical classification of pulmonary hypertensionPublished by Elsevier ,2004
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Prediction of Life Expectancy in Patients with Primary Pulmonary Hypertension. A Retrospective Nationwide Survey from 1980-1990.Internal Medicine, 1999
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976